121.68
Real-Time Quote
 +7.22 / +6.31%
Today’s Change
24.53
Today|||52-Week Range
135.37
+319.73%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$3.6B

Company Description

Receptos, Inc. is a biopharmaceutical company. It discovers, develops and commercializes innovative therapeutics for immune disorders. The company clinical pipeline includes RPC1063 and RPC4046. The RPC1063 is being developed as an oral therapy for the treatment of relapsing multiple sclerosis (RMS) and inflammatory bowel disease (IBD). The RPC4046 developed for the treatment of an allergic/immune-mediated disorder, eosinophilic esophagitis (EoE), which is an orphan disease. Receptos was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA.

Contact Information

Receptos, Inc.
10835 Road to the Cure
San Diego California 92121
P:(858) 652-5700
Investor Relations:

Employees

Shareholders

Other institutional44.52%
Mutual fund holders39.19%
Individual stakeholders22.67%

Top Executives

Faheem HasnainPresident, Chief Executive Officer & Director
Graham K. CooperCFO, CAO, Head-Investor & Media Relations
Robert J. PeachChief Scientific Officer
Marcus F. BoehmChief Technology Officer
Sheila GujrathiChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.